Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Rocket Pharmaceuticals Inc’s stock clocked out at $3.56, down -5.57% from its previous closing price of $3.77. In other words, the price has decreased by -$5.57 from its previous closing price. On the day, 2.76 million shares were traded. RCKT stock price reached its highest trading level at $3.85 during the session, while it also had its lowest trading level at $3.42.
Ratios:
To gain a deeper understanding of RCKT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.39 and its Current Ratio is at 6.39. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On July 25, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $4.
Evercore ISI Downgraded its Outperform to In-line on May 30, 2025, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 14 ’25 when Militello John sold 28,918 shares for $3.96 per share. The transaction valued at 114,581 led to the insider holds 67,006 shares of the business.
Militello John bought 28,918 shares of RCKT for $114,581 on Oct 14 ’25. On Aug 27 ’25, another insider, Bjork Elisabeth, who serves as the Director of the company, bought 10,000 shares for $3.41 each. As a result, the insider paid 34,100 and bolstered with 40,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 384137792 and an Enterprise Value of 137845776.
Stock Price History:
The Beta on a monthly basis for RCKT is 0.70, which has changed by -0.78068644 over the last 52 weeks, in comparison to a change of 0.18286073 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $18.17, while it has fallen to a 52-week low of $2.19. The 50-Day Moving Average of the stock is 3.21%, while the 200-Day Moving Average is calculated to be -34.15%.
Shares Statistics:
It appears that RCKT traded 3.56M shares on average per day over the past three months and 1708640 shares per day over the past ten days. A total of 107.88M shares are outstanding, with a floating share count of 98.66M. Insiders hold about 8.57% of the company’s shares, while institutions hold 85.56% stake in the company. Shares short for RCKT as of 1760486400 were 12397844 with a Short Ratio of 3.48, compared to 1757894400 on 14892250. Therefore, it implies a Short% of Shares Outstanding of 12397844 and a Short% of Float of 22.37.
Earnings Estimates
The stock of Rocket Pharmaceuticals Inc (RCKT) is currently drawing attention from 14.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.33 and low estimates of -$0.61.
Analysts are recommending an EPS of between -$1.69 and -$2.36 for the fiscal current year, implying an average EPS of -$2.13. EPS for the following year is -$1.11, with 12.0 analysts recommending between $0.69 and -$1.96.
